Neupogen

Neupogen Description

filgrastim

Manufacturer:

Amgen

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Neupogen Vial 30 MU/ml: Each vial contains 30 million units (MU)/300 micrograms (μg) of filgrastim in 1 ml (0.3 mg/ml).
Filgrastim (recombinant methionyl human granulocyte-colony stimulating factor) is produced by r-DNA technology in E. coli (K12).
Excipient with known effect: Each ml of solution contains 0.0010 to 0.0022 mmol or 0.023 to 0.051 mg sodium and 50 mg sorbitol (E420).
Neupogen Pre-filled Syringe 30 MU/0.5 ml: Each pre-filled syringe contains 30 million units (MU)/300 micrograms (μg) of filgrastim in 0.5 ml (0.6 mg/ml).
Filgrastim (recombinant methionyl human granulocyte-colony stimulating factor) is produced by r-DNA technology in E. coli (K12).
Excipient with known effect: Each ml of solution contains 0.0015 to 0.0023 mmol or 0.035 to 0.052 mg sodium and 50 mg of sorbitol (E420).
Excipients/Inactive Ingredients: Sodium Acetate*, Sorbitol (E420), Polysorbate 80, Water for Injections.
*Sodium acetate is formed by titrating glacial acetic acid with sodium hydroxide.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in